Literature DB >> 15248867

MAO-B knockout mice exhibit deficient habituation of locomotor activity but normal nicotine intake.

M Lee1, K Chen, J C Shih, N Hiroi.   

Abstract

Low levels of monoamine oxidase-B (MAO-B) activity, such as those observed in smokers, are also associated with behavioral traits such as a heightened responsiveness to novelty. However, the exact mechanism by which low MAO-B activity influences smoking and heightened responsiveness to novelty is still poorly understood. We used MAO-B knockout (KO) mice to test the hypothesis that MAO-B concomitantly affects locomotor responses in a novel inescapable open field and nicotine intake. Male wild-type (WT) and MAO-B KO mice were placed in an inescapable open field and their horizontal locomotor activity was measured for 30 min per day for 5 days. MAO-B KO mice exhibited impaired within-session habituation of locomotor activity, as compared to WT mice. Separate groups of male WT and MAO-B KO mice were individually housed in their home cages with two water bottles. One of the bottles contained tap water and the other contained nicotine (0, 3.125, 6.25, 12.5, 25, 50 or 100 micro g/ml). The total amount of water and nicotine solution consumed was measured every three days for 16 days. MAO-B KO mice and WT mice consumed equal amounts of nicotine and exhibited comparable concentration-dependent nicotine preference and aversion over a period of 16 days. The data suggest that the absence of MAO-B impairs the ability of mice to habituate in the inescapable environment, but does not alter their nicotine intake.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15248867     DOI: 10.1111/j.1601-1848.2004.00074.x

Source DB:  PubMed          Journal:  Genes Brain Behav        ISSN: 1601-183X            Impact factor:   3.449


  12 in total

Review 1.  Mouse models for studying genetic influences on factors determining smoking cessation success in humans.

Authors:  F Scott Hall; Athina Markou; Edward D Levin; George R Uhl
Journal:  Ann N Y Acad Sci       Date:  2012-02       Impact factor: 5.691

2.  A 200-kb region of human chromosome 22q11.2 confers antipsychotic-responsive behavioral abnormalities in mice.

Authors:  Noboru Hiroi; Hongwen Zhu; Moonsook Lee; Birgit Funke; Makoto Arai; Masanari Itokawa; Raju Kucherlapati; Bernice Morrow; Takehito Sawamura; Soh Agatsuma
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-19       Impact factor: 11.205

3.  Individual differences in oral nicotine intake in rats.

Authors:  Tanseli Nesil; Lutfiye Kanit; Allan C Collins; Sakire Pogun
Journal:  Neuropharmacology       Date:  2011-04-12       Impact factor: 5.250

Review 4.  Constitutional mechanisms of vulnerability and resilience to nicotine dependence.

Authors:  N Hiroi; D Scott
Journal:  Mol Psychiatry       Date:  2009-02-24       Impact factor: 15.992

5.  Behavioral disinhibition and reduced anxiety-like behaviors in monoamine oxidase B-deficient mice.

Authors:  Marco Bortolato; Sean C Godar; Shieva Davarian; Kevin Chen; Jean C Shih
Journal:  Neuropsychopharmacology       Date:  2009-08-26       Impact factor: 7.853

6.  Sex differences in response to nicotine in C57Bl/6:129SvEv mice.

Authors:  Carolina Isiegas; Stephen D Mague; Julie A Blendy
Journal:  Nicotine Tob Res       Date:  2009-05-29       Impact factor: 4.244

7.  Oral Nicotine Self-Administration in Rodents.

Authors:  Allan C Collins; Sakire Pogun; Tanseli Nesil; Lutfiye Kanit
Journal:  J Addict Res Ther       Date:  2012-06-01

8.  Variation in nicotine consumption in inbred mice is not linked to orosensory ability.

Authors:  A Rebecca Glatt; Kelley Denton; John D Boughter
Journal:  Chem Senses       Date:  2008-09-04       Impact factor: 3.160

Review 9.  Monoamine oxidase inactivation: from pathophysiology to therapeutics.

Authors:  Marco Bortolato; Kevin Chen; Jean C Shih
Journal:  Adv Drug Deliv Rev       Date:  2008-07-04       Impact factor: 15.470

10.  Age-related behavioral phenotype of an astrocytic monoamine oxidase-B transgenic mouse model of Parkinson's disease.

Authors:  Christopher A Lieu; Shankar J Chinta; Anand Rane; Julie K Andersen
Journal:  PLoS One       Date:  2013-01-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.